Korean Journal of Family Practice

Table. 1.

Comparison on the key features of COVID-19 vaccines licensed in the KCDC

Platform mRNA Viral vector
Manufacturer Pfizer BioNTech Moderna Oxford AstraZeneca Janssen (J&J)
Vaccine name Comirnaty Inj. Moderna Covid-19 Vaccine Inj. Astra Zeneca Covid-19 Vaccine Inj. Covid-19 Vaccine Janssen Inj.
Age group 12 y and above 18 y and above 18 y and above 18 y and above
Vial Multiple dose vial Multiple dose vial Multiple dose vial Multiple dose vial
Dose and frequency 2 doses, 21 days apart 2 doses, 28 days apart 2 doses, 4–12 weeks 1 dose
Dosage and route of administration Diluted vaccine 0.3 mL
Intramuscular injection
0.5 mL
Intramuscular injection
0.5 mL
Intramuscular injection
0.5 mL
Intramuscular injection
Cold chain requirements -90°C to -60°C (6 months) -25°C to 15°C (7 months) 2°C to 8°C (6 months) -25°C to -15°C (24 months)
Storage requirements -90°C to -60°C (6 months)
2°C to 8°C (5 days)
2°C to 8°C (30 days) 2°C to 8°C (6 months) 2°C to 8°C (3 months)
Punctured vial and shelf life After dilution
Up to 25°C
Within 6 hours
Up to 25°C
Within 6 hours
Up to 30°C
Within 6 hours
2°C to 8°C
Within 6 hours
Up to 25°C
Within 3 hours

Adapted from the article of Korea Disease Control and Prevention Agency.2)

COVID-19, coronavirus disease 2019; KCDC, Korean Centers for Disease Control; Inj, injection.

Korean J Fam Pract 2021;11:236~246 https://doi.org/10.21215/kjfp.2021.11.4.236
© KJFP